You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
How IQVIA’s unchecked growth could come to a halt
Health data giant IQVIA’s unbridled growth might come to a halt as regulators begin to rein in its acquisitions, Casey Ross writes. A Federal Trade Commission lawsuit aims to block IQVIA’s plan to scoop up digital advertising company DeepIntent, and argues that the scope and sprawl of the company’s data could lead to a deluge of ads targeting patients and doctors.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect